Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Recent Advances with KDM4 Inhibitors and Potential Applications
Qiong Wu, Brandon Young, Yan Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9564-9579
Open Access | Times Cited: 25
Modeling the anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Activity of (E)-6-chloro-N 2 -phenyl-N 4 -(4-Phenyl-5-(Phenyl Diazinyl)-2λ 3 , 3 λ 2 - Thiazol-2-yl)-1, 3, 5-Triazine-2,4- Diamine
Innocent Benjamin, Hitler Louis, Francis O. Ekpen, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 9, pp. 7942-7969
Closed Access | Times Cited: 25
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
Guan‐Jun Yang, Changyun Li, Tao Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 645-663
Open Access | Times Cited: 11
Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu, Ming-Jie Huang, Jia–Wen Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112760-112760
Closed Access | Times Cited: 30
Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
Yi Wang, Qiang Xie, Huidan Tan, et al.
Pharmacological Research (2021) Vol. 173, pp. 105702-105702
Closed Access | Times Cited: 27
Unravelling KDM4 histone demethylase inhibitors for cancer therapy
Stephin Baby, Durgesh Gurukkala Valapil, Nagula Shankaraiah
Drug Discovery Today (2021) Vol. 26, Iss. 8, pp. 1841-1856
Closed Access | Times Cited: 24
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present)
Xingrui He, Hang Zhang, Yingqian Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114143-114143
Closed Access | Times Cited: 19
Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase
Thomas P. Corner, Anthony Tumber, E. Salah, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Exploring the potential of histone demethylase inhibition in multi-therapeutic approaches for cancer treatment
Deping Li, Hailiu Liang, Yifei Wei, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115999-115999
Closed Access | Times Cited: 6
Dimethylamination of Primary Alcohols Using a Homogeneous Iridium Catalyst: A Synthetic Method for N,N-Dimethylamine Derivatives
Jaeyoung Jeong, Ken‐ichi Fujita
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 5, pp. 4053-4060
Closed Access | Times Cited: 14
2‐Aryl‐2,4‐dihydro‐5H‐[1,2,3]triazolo[4,5‐d]pyrimidin‐5‐ones as a New Platform for the Design and Synthesis of Biosensors and Chemosensors
Alexander K. Eltyshev, Артем С. Минин, Leonid T. Smoliuk, et al.
European Journal of Organic Chemistry (2019) Vol. 2020, Iss. 3, pp. 316-329
Closed Access | Times Cited: 10
KDM4 Demethylases: Structure, Function, and Inhibitors
Yuanyuan Jiang, Lanxin Liu, Zeng-Quan Yang
Advances in experimental medicine and biology (2023), pp. 87-111
Closed Access | Times Cited: 3
Inhibitors of Jumonji-C domain-containing histone demethylases
Veronica Sian, José A. Souto, Rosana Álvarez, et al.
Elsevier eBooks (2023), pp. 407-457
Closed Access
Page 1

Scroll to top